title: Long-term clinical results of IPL photorejuvenation.
abstract: BACKGROUND
  Non-ablative photorejuvenation is characterized by the reduction of intrinsic and extrinsic changes in photodamaged skin. Only short-term improvement has been documented previously.
  
  
  OBJECTIVE
  To evaluate quantitatively the short-term and long-term clinical effectiveness of multiple full-face IPL treatments for non-ablative facial photorejuvenation.
  
  
  METHODS
  A total of 47 patients with varying degrees of photodamaged skin and rosaceal dermatitis underwent a series of four to five IPL treatments with a Vasculight (Lumenis Corp). Treatments were conducted every 3-4 weeks. Photographs were taken at baseline and after the treatment series was completed at both 6 weeks and 6 months. Adverse effects and clinical improvement were documented. A patient satisfaction questionnaire was completed and reviewed at the 6-month evaluation period.
  
  
  RESULTS
  Standardized evaluation of rhytids showed a statistically significant improvement in wrinkles at both evaluation endpoints. Some degradation occurred over time. Facial vascularity, dyschromia, and large pore size progressively improved from the 6-week measurement to the 6-month measurement.
  
  
  CONCLUSIONS
  This clinical study demonstrates that non-ablative facial rejuvenation is associated with long-term clinical improvement of facial rhytids, abnormal vascularity and pigmentary disorders with minimal risks and side effects to the patient.
authors.affiliation: Olympic Dermatology and Laser Clinic, 424 Lilly Road NE, Suite A, Olympia, WA 98516, USA.
authors.forename: James
authors.initials: J
authors.lastname: Brazil
authors.forename: Patti
authors.initials: P
authors.lastname: Owens
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D003872:Dermatitis / Q000628:therapy; D004890:Erythema / Q000628:therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010789:Phototherapy; D010859:Pigmentation Disorders / Q000628:therapy; D015595:Skin Aging; D016896:Treatment Outcome